Subscribe: Brightsurf Science News :: Prostate Cancer News
Added By: Feedage Forager Feedage Grade A rated
Language: English
blood  breast cancer  breast  cancer researchers  cancer  new  oral  organ models  prostate cancer  prostate  researchers  rna  study  test 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Brightsurf Science News :: Prostate Cancer News

Prostate Cancer Current Events and Prostate Cancer News from Brightsurf

Prostate Cancer Current Events and Prostate Cancer News Events, Discoveries and Articles from Brightsurf

Copyright: Copyright 2017,

Medical marijuana for children with cancer? What providers think

Tue, 12 Dec 17 00:16:10 -0800

Most providers willing to consider medical marijuana use in children with cancer, but those with legal eligibility to certify are less likely to approve.

'Black box' recorder puts surgeons' robotic surgery skills under the microscope

Mon, 11 Dec 17 00:10:00 -0800

A new study from Keck Medicine of USC finds that data from a novel recorder can be used to objectively measure surgeons' proficiency in robotic-assisted prostate cancer surgery.

A new weapon against bone metastasis?

Mon, 11 Dec 17 00:04:50 -0800

A new antibody developed by Princeton researchers fights bone metastasis by undermining cancer's defense strategy and allowing chemotherapy to work.

Report: New system for more accurate cancer staging to aid precision medicine

Mon, 11 Dec 17 00:04:30 -0800

Adding a blood test called liquid biopsy to a standard tissue biopsy could significantly improve the accuracy of diagnosis and treatment for patients with cancer, according to researchers at Wake Forest Baptist Medical Center.

Blueprints for anti-cancer drugs discovered in bacterial genomes

Mon, 11 Dec 17 00:10:50 -0800

New research suggests these hidden genes hold the blueprints for designing new, even more effective cancer-targeting compounds.

Insights on how SHARPIN promotes cancer progression

Mon, 11 Dec 17 00:12:40 -0800

SBP and Technion Institute researchers have SHARPIN-ed their knowledge of how a malicious form of a protein drives the formation of melanoma through modulation of the PRMT5 pathway. The new research was published in the Journal of Clinical Investigation.

Researchers invent novel RNA nanotech to decorate exosomes for effective cancer therapy

Mon, 11 Dec 17 00:13:50 -0800

A new study shows that attaching antibody-like RNA nanoparticles to microvesicles can deliver effective RNA therapeutics specifically to cancer cells. Researchers used RNA nanotechnology to apply the RNA nanoparticles and control their orientation. The microscopic, therapy-loaded extracellular vesicles successfully targeted three types of cancer in animal models. The findings could lead to a new generation of anticancer drugs that use siRNA, microRNA and other RNA-interference technologies.

Rapid responses, few adverse effects in targeted agent in Phase1 trial in rare blood disorder

Sun, 10 Dec 17 00:06:00 -0800

Clinical Activity in a Phase 1 Study of BLU-285, a Potent, Highly-Selective Inhibitor of KIT D816V in Advanced Systemic Mastocytosis. Study shows one of multiple ways in which novel targeted cancer therapies are now being deployed to improve outcomes and quality of life for patients with rare, advanced, or difficult-to-treat blood malignancies.

ECOG-ACRIN discovers a simple blood test may predict recurrence of breast cancer

Fri, 08 Dec 17 00:15:40 -0800

Late recurrence five+ years after surgery accounts for at least half of all breast cancer recurrences. There are no tests that identify who is at highest risk. ECOG-ACRIN Cancer Research Group researchers studied a blood test for circulating tumor cells, finding that in women cancer-free five after diagnosis, 5% had a positive test, which was associated with a 35% recurrence risk after two years, compared with only 2% with a negative test. Findings require follow-up.

Community practices not following guidelines for MRI breast cancer screening

Thu, 07 Dec 17 00:09:20 -0800

Guidelines are not being followed to ensure that breast cancer screening of high risk women, such as those with a strong family history of breast cancer, includes an additional MRI (magnetic resonance imaging) scan. Deirdre A. Hill of the University of New Mexico School of Medicine led a study on this in the Journal of General Internal Medicine which is published by Springer.

Researchers make important bacterial discovery in oral pre-cancer condition

Thu, 07 Dec 17 00:09:40 -0800

Scientists at the School of Dental Science in Trinity have made an important discovery involving bacteria and a pre-cancerous growth called oral leuoplakia which can precede oral cancer. The researchers examined the microbiome of oral leukoplakia in order to determine if certain bacteria were associated with oral leukoplakia and whether the type of bacteria could predict whether these condition become malignant.

Biological factors don't fully explain racial disparities for breast cancer type

Thu, 07 Dec 17 00:13:30 -0800

The biological features of patients' tumors partially explained a racial disparity for women with hormone receptor-positive, HER2-negative breast cancer, but UNC Lineberger Comprehensive Cancer Center researchers said it didn't explain it completely. The preliminary findings were reported at the 2017 San Antonio Breast Cancer Symposium.

Breakthroughs in understanding the genetic basis of aggressive prostate cancer

Wed, 06 Dec 17 00:10:20 -0800

New research shows how losing a ubiquitous gene opens genetic floodgates that make prostate cancer deadly, a finding that could apply to many cancers.

Researchers 3-D print lifelike artificial organ models

Wed, 06 Dec 17 00:12:00 -0800

A team of researchers led by the University of Minnesota has 3D printed lifelike artificial organ models that mimic the exact anatomical structure, mechanical properties, and look and feel of real organs. These patient-specific organ models, which include integrated soft sensors, can be used for practice surgeries to improve surgical outcomes in thousands of patients worldwide.

Diabetes drug metformin inhibits multidrug-resistant breast cancer
The drug metformin, typically prescribed to treat type 2 diabetes, keeps breast cancer cells from developing multiple drug resistance (MDR) and can reverse MDR after it